These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38673922)

  • 1. Novel Findings on CCR1 Receptor in CNS Disorders: A Pathogenic Marker Useful in Controlling Neuroimmune and Neuroinflammatory Mechanisms in Parkinson's Disease.
    Repici A; Capra AP; Hasan A; Bulzomì M; Campolo M; Paterniti I; Esposito E; Ardizzone A
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective Effect of Ceftriaxone on MPTP-Induced Parkinson's Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota.
    Zhou X; Lu J; Wei K; Wei J; Tian P; Yue M; Wang Y; Hong D; Li F; Wang B; Chen T; Fang X
    Oxid Med Cell Longev; 2021; 2021():9424582. PubMed ID: 34938384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUN11602, a bFGF mimetic, modulated neuroinflammation, apoptosis and calcium-binding proteins in an in vivo model of MPTP-induced nigrostriatal degeneration.
    Ardizzone A; Bova V; Casili G; Filippone A; Campolo M; Lanza M; Esposito E; Paterniti I
    J Neuroinflammation; 2022 May; 19(1):107. PubMed ID: 35526035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models.
    Park JE; Leem YH; Park JS; Kim DY; Kang JL; Kim HS
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson' disease mice.
    He Y; Zhao J; Dong H; Zhang X; Duan Y; Ma Y; Yu M; Fei J; Huang F
    Life Sci; 2023 Nov; 333():122171. PubMed ID: 37827233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson's disease model.
    Qiu J; Chen Y; Zhuo J; Zhang L; Liu J; Wang B; Sun D; Yu S; Lou H
    Neuropharmacology; 2022 Apr; 207():108963. PubMed ID: 35065082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baohuoside I suppresses the NLRP3 inflammasome activation via targeting GPER to fight against Parkinson's disease.
    Gu Y; Hu ZF; Zheng DW; Yang YQ; Dong XL; Chen WF
    Phytomedicine; 2024 Apr; 126():155435. PubMed ID: 38394727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson's disease, and alters gut microbiota and metabolite composition.
    Meng T; Zhang Y; Huang J; Pandey V; Fu S; Ma S
    Phytomedicine; 2024 Feb; 124():155309. PubMed ID: 38237261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation.
    He Z; Hu Y; Zhang Y; Xie J; Niu Z; Yang G; Zhang J; Zhao Z; Wei S; Wu H; Hu W
    Phytomedicine; 2024 May; 127():155494. PubMed ID: 38471370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRK2 regulates ferroptosis through the system Xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease.
    Zheng Z; Zhang S; Liu X; Wang X; Xue C; Wu X; Zhang X; Xu X; Liu Z; Yao L; Lu G
    J Cell Physiol; 2024 May; 239(5):e31250. PubMed ID: 38477420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Transcription Factor Nrf2 Mediates the Effects of
    Lanza M; Cucinotta L; Casili G; Filippone A; Basilotta R; Capra AP; Campolo M; Paterniti I; Cuzzocrea S; Esposito E
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease.
    Esposito E; Impellizzeri D; Mazzon E; Paterniti I; Cuzzocrea S
    PLoS One; 2012; 7(8):e41880. PubMed ID: 22912680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tomentosin Reduces Behavior Deficits and Neuroinflammatory Response in MPTP-Induced Parkinson's Disease in Mice.
    Fan Y; Maghimaa M; Chinnathambi A; Alharbi SA; Veeraraghavan VP; Mohan SK; Hussain S; Rengarajan T
    J Environ Pathol Toxicol Oncol; 2021; 40(1):75-84. PubMed ID: 33639075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models.
    Lee YY; Park JS; Leem YH; Park JE; Kim DY; Choi YH; Park EM; Kang JL; Kim HS
    J Neuroinflammation; 2019 Dec; 16(1):246. PubMed ID: 31791357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the TLR/NF-
    Su Y; Li M; Wang Q; Xu X; Qin P; Huang H; Zhang Y; Zhou Y; Yan J
    Oxid Med Cell Longev; 2022; 2022():1837278. PubMed ID: 36589679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson's disease models.
    Liu Z; Shen C; Li H; Tong J; Wu Y; Ma Y; Wang J; Wang Z; Li Q; Zhang X; Dong H; Yang Y; Yu M; Wang J; Zhou R; Fei J; Huang F
    J Neuroinflammation; 2023 Apr; 20(1):96. PubMed ID: 37072793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease.
    Ma C; Liu Y; Li S; Ma C; Huang J; Wen S; Yang S; Wang B
    CNS Neurosci Ther; 2023 Jul; 29(7):2018-2035. PubMed ID: 36914567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective role of chloroquine via modulation of autophagy and neuroinflammation in MPTP-induced Parkinson's disease.
    Kartik S; Pal R; Chaudhary MJ; Nath R; Kumar M; Binwal M; Bawankule DU
    Inflammopharmacology; 2023 Apr; 31(2):927-941. PubMed ID: 36715843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.